EyePoint Pharmaceuticals stock forecast
EyePoint Pharmaceuticals (PV3B) Stock Forecast & Price Target
PV3B Analyst Ratings
PV3B Stock 12 Month Forecast
Average Price Target
€2.35▲(834.49% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Annabel Samimy | Stifel Nicolaus | €5.47→€4.56 | buy | 1708.69%Upside | Reiterated | 11/13/26 | ||
| Yi Chen | H.C. Wainwright | ― | hold | ― | Reiterated | 11/13/26 | ||
| Yatin Suneja | Guggenheim | ― | hold | ― | Reiterated | 11/13/26 | ||
| Lisa Walter | RBC Capital | €0.91 | hold | 261.74%Upside | Reiterated | 11/12/26 | ||
| Debanjana Chatterjee | JonesTrading | ― | hold | ― | Downgraded | 10/23/26 | ||
| Yigal Nochomovitz | Citi | €15.50→€3.65 | buy | 1346.95%Upside | Reiterated | 10/20/26 | ||
| Graig Suvannavejh | Mizuho Securities | €35.55→€0.46 | hold | 80.87%Upside | Downgraded | 10/20/26 | ||
| Yale Jen | Laidlaw | ― | hold | ― | Downgraded | 10/20/26 | ||
| Faisal Khurshid | Jefferies | €7.29→€0.91 | hold | 261.74%Upside | Downgraded | 10/19/26 | ||
| Andreas Argyrides | Chardan Capital | ― | hold | ― | Reiterated | 10/19/26 | ||
| Tessa Romero | J.P. Morgan | ― | sell | ― | Downgraded | 10/19/26 | ||
| Steven Seedhouse | Cantor Fitzgerald | ― | hold | ― | Reiterated | 10/19/26 | ||
| Tara Bancroft | TD Cowen | €18.23→€3.65 | hold | 1346.95%Upside | Downgraded | 09/01/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Annabel SamimyStifel Nicolaus | BuyReiterated€5.47→€4.56 | 11/13/26 | 1708.69%Upside | ||
| Yi ChenH.C. Wainwright | HoldReiterated | 11/13/26 | ― | ||
| Yatin SunejaGuggenheim | HoldReiterated | 11/13/26 | ― | ||
| Lisa WalterRBC Capital | HoldReiterated€0.91 | 11/12/26 | 261.74%Upside | ||
| Debanjana ChatterjeeJonesTrading | HoldDowngraded | 10/23/26 | ― | ||
| Yigal NochomovitzCiti | BuyReiterated€15.50→€3.65 | 10/20/26 | 1346.95%Upside | ||
| Graig SuvannavejhMizuho Securities | HoldDowngraded€35.55→€0.46 | 10/20/26 | 80.87%Upside | ||
| Yale JenLaidlaw | HoldDowngraded | 10/20/26 | ― | ||
| Faisal KhurshidJefferies | HoldDowngraded€7.29→€0.91 | 10/19/26 | 261.74%Upside | ||
| Andreas ArgyridesChardan Capital | HoldReiterated | 10/19/26 | ― | ||
| Tessa RomeroJ.P. Morgan | SellDowngraded | 10/19/26 | ― | ||
| Steven SeedhouseCantor Fitzgerald | HoldReiterated | 10/19/26 | ― | ||
| Tara BancroftTD Cowen | HoldDowngraded€18.23→€3.65 | 09/01/26 | 1346.95%Upside |
Best Analysts Covering EyePoint Pharmaceuticals
Copying Tessa Romero's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +5.87% per trade.
Copying Tessa Romero's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +0.14% per trade.
Copying Tessa Romero's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -5.21% per trade.
PV3B Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 22 | 28 | 22 | 17 | 6 |
| Buy | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 5 | 6 | 15 | 13 |
| Sell | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 23 | 33 | 28 | 33 | 20 |
In the current month, PV3B has received 6 Buy Ratings, 13 Hold Ratings, and 1 Sell Ratings. PV3B average Analyst price target in the past 3 months is 2.35.
PV3B Financial Forecast
PV3B Earnings Forecast
Next quarter’s earnings estimate for PV3B is -EUR 0.63 with a range of -EUR 0.85 to -EUR 0.36. The previous quarter’s EPS was -EUR 0.98. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
PV3B Sales Forecast
Next quarter’s sales forecast for PV3B is EUR 277.12K with a range of EUR 0 to EUR 911.58K. The previous quarter’s sales results were EUR 689.15K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

